HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kinnula, V L Articles by Soini, Y Search for Related Content PubMed PubMed Citation Articles by Kinnula, V L Articles by Soini, Y

Cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis

¹ Departments of Internal Medicine and Pathology, University of Oulu and Oulu University Hospital, Finland
² Laboratory of Cell Signalling, National Institutes of Health, Bethesda, Maryland 20892, USA

Correspondence to:
Correspondence to:
Dr V Kinnula, University of Oulu, Department of Internal Medicine, Pulmonary Division, P O Box 5000 (Kajaanintie 50A), FIN-90014 Oulun Yliopisto, Finland;
vuokko.kinnula{at}oulu.fiorvuokko.kinnula{at}ppshp.fi

Background: Six proteins of the peroxiredoxin (Prx) family have recently been characterised which have the capacity to decompose hydrogen peroxide in vivo and in vitro. These proteins may have an important role in the protection of human lung against endogenous and exogenous oxidant stress. However, the expression and distribution of these proteins in healthy human lung and diseased lung tissue is unknown.

Methods: The cell specific expression of Prxs in healthy lung tissue from four non-smokers and in parenchymal tissue from 10 subjects with pulmonary sarcoidosis was investigated by immunohistochemistry, and expression of these proteins in various cultured lung cells and cells of bronchoalveolar lavage (BAL) fluid of controls and patients with sarcoidosis was assessed by Western blot analysis.

Results: All six Prxs could be synthesised in cultured human lung cells. The bronchial epithelium showed moderate to high expression of Prxs I, III, V and VI, the alveolar epithelium expressed mainly Prxs V and VI, and alveolar macrophages expressed mainly Prxs I and III. Granulomas of subjects with sarcoidosis expressed mainly Prxs I and III. Samples of BAL fluid from controls and from subjects with sarcoidosis had very similar findings, except that Prxs II and III had a tendency for increased immunoreactivity in sarcoidosis tissue.

Conclusions: Prxs I, III, V, and VI, in particular, have prominent and cell specific expression in human lung tissue. High expression of Prxs I and III in granulomas and alveolar macrophages of sarcoidosis parenchyma may have a significant effect on the oxidant burden and the progression of lung injury in this disease.

Keywords: peroxiredoxin; sarcoidosis; hydrogen peroxide

This article has been cited by other articles:

				A. Nadeem, A. Masood, and N. Siddiqui Review: Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options Therapeutic Advances in Respiratory Disease, August 1, 2008; 2(4): 215 - 235. [Abstract] [PDF]

				A. L. Mowbray, D.-H. Kang, S. G. Rhee, S. W. Kang, and H. Jo Laminar Shear Stress Up-regulates Peroxiredoxins (PRX) in Endothelial Cells: PRX 1 AS A MECHANOSENSITIVE ANTIOXIDANT J. Biol. Chem., January 18, 2008; 283(3): 1622 - 1627. [Abstract] [Full Text] [PDF]

				Y. Iwata, F. Ogawa, K. Komura, E. Muroi, T. Hara, K. Shimizu, M. Hasegawa, M. Fujimoto, Y. Tomita, and S. Sato Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress Rheumatology, May 1, 2007; 46(5): 790 - 795. [Abstract] [Full Text] [PDF]

				V L Kinnula Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases Thorax, August 1, 2005; 60(8): 693 - 700. [Abstract] [Full Text] [PDF]

				S. T. Lehtonen, P. M. H. Markkanen, M. Peltoniemi, S. W. Kang, and V. L. Kinnula Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L997 - L1001. [Abstract] [Full Text] [PDF]

				J. D. Crapo Redox Active Agents in Inflammatory Lung Injury Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1027 - 1028. [Full Text]

				V. L. Kinnula and J. D. Crapo Superoxide Dismutases in the Lung and Human Lung Diseases Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1600 - 1619. [Abstract] [Full Text] [PDF]